Evergen
Chad Croasdale is a seasoned executive with extensive experience in the medical device and rehabilitation industries. Currently serving as the Chief Commercial Officer at RTI Surgical® since June 2024, Chad has previously held leadership roles such as President & Chief Commercial Officer at 270Surgical from 2018 to July 2024, and Vice President, General Manager at Stryker from 2009 to 2018. Chad's career at Stryker also included positions as VP of Marketing, General Manager of the GI division, and various sales management roles, contributing significantly to product development, marketing strategies, and revenue growth. Prior to Stryker, Chad managed an outpatient rehabilitation clinic at NovaCare and practiced as a Physical Therapist. Educational credentials include a Bachelor's degree in Psychology from Hobart and William Smith Colleges, a Master's in Physical Therapy from Widener University, and several executive education certificates from prestigious institutions, including Harvard Business School and Texas McCombs School of Business.
This person is not in any offices
Evergen
4 followers
Evergen is a leading Contract Development and Manufacturing Organization (CDMO) pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine. We are expert partners to Original Equipment Manufacturers (OEMs), working with them to identify clinical problems and develop customized solutions that promote healing, accelerate recovery, and help prevent complications. Using our extensive portfolio of biological materials, we focus on specialized clinical segments, including plastic and reconstructive surgery, sports medicine and orthopedics, cardiac, and neurosurgery.